Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 Diabetes (RAISE)
This study has been completed.
Daiichi Sankyo Co., Ltd.
Information provided by:
Daiichi Sankyo, Inc.
First received: December 14, 2007
Last updated: February 6, 2009
Last verified: February 2009
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2009|
|Primary Completion Date:||June 2008 (Final data collection date for primary outcome measure)|